Revenue growth should surely be returning after that little 2021...

  1. 9,067 Posts.
    lightbulb Created with Sketch. 7850
    Revenue growth should surely be returning after that little 2021 slump? Look forward to the Appendix 4C. Commiserations to long-term holders. I appreciate I am only just joining the holders at good levels by comparison. After been invested in many bio-techs with quality products and yet poor financial returns I appreciate the frustration. Still fundamentally a very promising company if they return to those growing revenues out of the grips of COVID.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.2¢
Change
0.000(0.00%)
Mkt cap ! $2.081M
Open High Low Value Volume
1.3¢ 1.3¢ 1.2¢ $13.22K 1.094M

Buyers (Bids)

No. Vol. Price($)
3 446472 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 557877 3
View Market Depth
Last trade - 15.25pm 18/06/2025 (20 minute delay) ?
OSX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.